Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | Q9HBH1 | 1/20 | 0.31 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Peroxide SCHEMBL15855960 | 0.91 | CA2 (0.56) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL57471 | 0.90 | CA2 (0.58) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL10714547 | 0.85 | CA2 (0.56) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL12140593 | 0.85 | CA2 (0.56) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL21081722 | 0.84 | CA2 (0.50) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL31486196 | 0.82 | CA2 (0.49) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL8729030 | 0.81 | CA2 (0.51) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL28324938 | 0.81 | CA2 (0.47) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL218700 | 0.81 | CA2 (0.58) | CA2CA1MAPK1ATMGAA | |
| SCHEMBL38657779 | 0.80 | CA2 (0.41) | CA2CA1MAPK1ATMGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577432-B2 | Organosilicon compound, production method therefor, and curable composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4282653-B1 | ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2026-02-25 | — | — | EP | disclosed |
| US-12522684-B2 | Active-energy-ray-curable resin composition and cured product thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| EP-4159779-B1 | ACTIVE-ENERGY-RAY-CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF | NIPPON CATALYTIC CHEM IND (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-20240101723-A1 | METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER LATEX | ZEON CORPORATION (JP) | 2024-03-28 | — | — | US | disclosed |
| US-20240059929-A1 | ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-02-22 | — | — | US | disclosed |
| EP-4299272-A1 | METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER LATEX | Zeon Corporation (JP) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023238925-A1 | RADICAL POLYMERIZABLE COMPOSITION AND POLYMERIZED PRODUCT THEREOF | 株式会社日本触媒 | 2023-12-14 | — | — | WO | disclosed |
| EP-4282653-A1 | ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023167186-A1 | POLYMERIZABLE COMPOSITION | 株式会社日本触媒 | 2023-09-07 | — | — | WO | disclosed |
| EP-2626374-A1 | DIENE-BASED CARBOXYLATE ANION AND SALT THEREOF, AND POLYMERIZABLE OR CURABLE COMPOSITION THEREOF | Nippon Shokubai Co., Ltd. (JP) | 2013-08-14 | — | — | EP | disclosed |
| US-20130197123-A1 | DIENE-BASED CARBOXYLATE ANION AND SALT THEREOF, AND POLYMERIZABLE OR CURABLE COMPOSITION THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2013-08-01 | — | — | US | disclosed |
| US-8399583-B2 | Polymer, curable resin composition, cured product, and article | NIPPON SHOKUBAI CO., LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20110009586-A1 | POLYMER, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ARTICLE | NIPPON SHOKUBAI CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-1569013-B1 | Curable composition for optical parts | NIPPON CATALYTIC CHEM IND (JP) | 2010-04-14 | — | — | EP | disclosed |
| EP-1772471-B1 | Radiation-curable composition and cured product thereof | NIPPON CATALYTIC CHEM IND (JP) | 2010-03-03 | — | — | EP | disclosed |
| EP-1772471-A1 | Radiation-curable composition and cured product thereof | Nippon Shokubai Co.,Ltd. (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-20070049655-A1 | Radiation-curable composition and cured product thereof | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20050192373-A1 | Curable composition for optical parts | NIPPON SHOKUBAI CO., LTD. | 2005-09-01 | — | — | US | disclosed |
| EP-1569013-A2 | Curable composition for optical parts | NIPPON SHOKUBAI CO., LTD. (JP) | 2005-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577432-B2 | Organosilicon compound, production method therefor, and curable composition | ASH2L, DOT1L, DNMT3L | CA2 145/4885CA1 13/4885MAPK1 2998/4885 |
| US-20240059929-A1 | ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION | CYP51A1, CYP4F11, FAR1 | CA2 1662/4885CA1 883/4885MAPK1 3528/4885 |
| US-20130197123-A1 | DIENE-BASED CARBOXYLATE ANION AND SALT THEREOF, AND POLYMERIZABLE OR CURABLE COMPOSITION THEREOF | MIF, DCTN1, CDH1 | CA2 64/4885CA1 40/4885MAPK1 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.